Centennial Surgical [CSURGSU] vs Tarsons Products [TARSONS] Detailed Stock Comparison
Centennial Surgical
BSE
Loading...
Tarsons Products
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Centennial Surgical wins in 8 metrics, Tarsons Products wins in 10 metrics, with 0 ties. Tarsons Products appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Centennial Surgical | Tarsons Products | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,482.50 | 66.74 | Tarsons Products |
| Price-to-Book Ratio | 1.82 | 3.15 | Centennial Surgical |
| Debt-to-Equity Ratio | 108.97 | 53.82 | Tarsons Products |
| PEG Ratio | N/A | 30.14 | N/A |
| EV/EBITDA | 16.07 | 19.95 | Centennial Surgical |
| Profit Margin (TTM) | -2.74% | 7.59% | Tarsons Products |
| Operating Margin (TTM) | 6.05% | 15.08% | Tarsons Products |
| EBITDA Margin (TTM) | 6.05% | 15.08% | Tarsons Products |
| Return on Equity | -4.65% | 4.79% | Tarsons Products |
| Return on Assets (TTM) | 1.53% | 2.94% | Tarsons Products |
| Free Cash Flow (TTM) | $56.05M | $-374.69M | Centennial Surgical |
| Dividend Yield | N/A | 0.53% | N/A |
| 1-Year Return | 40.78% | -11.67% | Centennial Surgical |
| Price-to-Sales Ratio (TTM) | 1.04 | 5.07 | Centennial Surgical |
| Enterprise Value | $891.12M | $22.09B | Tarsons Products |
| EV/Revenue Ratio | 1.67 | 5.63 | Centennial Surgical |
| Gross Profit Margin (TTM) | 73.40% | 66.37% | Centennial Surgical |
| Revenue per Share (TTM) | $147 | $74 | Centennial Surgical |
| Earnings per Share (Diluted) | $-4.01 | $5.60 | Tarsons Products |
| Beta (Stock Volatility) | 0.49 | 0.11 | Tarsons Products |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Centennial Surgical vs Tarsons Products Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Centennial Surgical | 1.29% | 5.12% | -1.90% | 24.05% | 14.39% | 13.97% |
| Tarsons Products | -3.75% | -0.35% | -2.02% | -0.03% | 5.28% | -7.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Centennial Surgical | 40.78% | 192.45% | 272.15% | 214.08% | 7,351.92% | 14,661.90% |
| Tarsons Products | -11.67% | -50.13% | -54.33% | -54.33% | -54.33% | -54.33% |
Performance & Financial Health Analysis: Centennial Surgical vs Tarsons Products
| Metric | CSURGSU | TARSONS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹558.19M | ₹19.89B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 134 | 23,739 |
| 90 Day Avg. Volume | 180 | 32,034 |
| Last Close | ₹157.00 | ₹359.75 |
| 52 Week Range | ₹82.15 - ₹169.50 | ₹280.00 - ₹494.95 |
| % from 52W High | -7.37% | -27.32% |
| All-Time High | ₹169.50 (Dec 16, 2024) | ₹924.90 (Nov 29, 2021) |
| % from All-Time High | -7.37% | -61.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.07% |
| Quarterly Earnings Growth | 0.10% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.08% |
| Operating Margin (TTM) | 0.06% | 0.15% |
| Return on Equity (TTM) | -0.05% | 0.05% |
| Debt to Equity (MRQ) | 108.97 | 53.82 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹84.30 | ₹118.59 |
| Cash per Share (MRQ) | ₹0.60 | ₹4.83 |
| Operating Cash Flow (TTM) | ₹170.74M | ₹1.14B |
| Levered Free Cash Flow (TTM) | ₹-42,696,752 | ₹-769,583,744 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.53% |
| Last 12-Month Dividend | N/A | ₹2.00 |
Valuation & Enterprise Metrics Analysis: Centennial Surgical vs Tarsons Products
| Metric | CSURGSU | TARSONS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,482.50 | 66.74 |
| Forward P/E | N/A | 30.14 |
| PEG Ratio | N/A | 30.14 |
| Price to Sales (TTM) | 1.04 | 5.07 |
| Price to Book (MRQ) | 1.82 | 3.15 |
| Market Capitalization | ||
| Market Capitalization | ₹558.19M | ₹19.89B |
| Enterprise Value | ₹891.12M | ₹22.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.67 | 5.63 |
| Enterprise to EBITDA | 16.07 | 19.95 |
| Risk & Other Metrics | ||
| Beta | 0.49 | 0.11 |
| Book Value per Share (MRQ) | ₹84.30 | ₹118.59 |
Financial Statements Comparison: Centennial Surgical vs Tarsons Products
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CSURGSU | TARSONS |
|---|---|---|
| Revenue/Sales | ₹133.08M | ₹1.13B |
| Cost of Goods Sold | ₹35.40M | ₹378.93M |
| Gross Profit | ₹97.68M | ₹747.98M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹8.05M | ₹169.95M |
| EBITDA | ₹21.17M | ₹408.04M |
| Pre-Tax Income | ₹-13.38M | ₹155.71M |
| Income Tax | ₹-1.54M | ₹53.68M |
| Net Income (Profit) | ₹-11.84M | ₹102.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CSURGSU | TARSONS |
|---|---|---|
| Cash & Equivalents | ₹2.20M | ₹251.31M |
| Total Current Assets | ₹629.64M | ₹2.43B |
| Total Current Liabilities | ₹318.30M | ₹1.76B |
| Long-Term Debt | N/A | ₹2.12B |
| Total Shareholders Equity | ₹307.55M | ₹6.30B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹199.83M | ₹4.72B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CSURGSU | TARSONS |
|---|---|---|
| Operating Cash Flow | N/A | ₹100.02M |
| Capital Expenditures | N/A | ₹-279.63M |
| Free Cash Flow | N/A | ₹-231.27M |
| Debt Repayment | N/A | ₹-754.90M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CSURGSU | TARSONS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 134 | 23,739 |
| Average Daily Volume (90 Day) | 180 | 32,034 |
| Shares Outstanding | 3.65M | 53.21M |
| Float Shares | 615,942 | 13.38M |
| % Held by Insiders | 0.81% | 0.75% |
| % Held by Institutions | 0.00% | 0.08% |
Dividend Analysis & Yield Comparison: Centennial Surgical vs Tarsons Products
| Metric | CSURGSU | TARSONS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹2.00 |
| Last 12-Month Dividend Yield | N/A | 0.53% |
| 3-Year Avg Annual Dividend | N/A | ₹0.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹2.00 |
| Ex-Dividend Date | N/A | Sep 20, 2024 |